Zanamivir

This classification denotes an antiviral agent with the molecular formula C12H20N4O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6O3XI777I, chemically known as 5-acetamido-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic acid but generally known as zanamivir, which bears US NIH Compound Identifier 60855. European Medicines Agency schedules Zanamivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00137MIG. The term ZANAMIVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules zanamivir in its Anatomical Therapeutic Chemical (ATC) Classification. ZANAMIVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zanamivir under HS 29329985 and SITC 51569. As of Q4 2014, ZANAMIVIR remains the US FDA Preferred Term for this commodity. Zanamivir bears US NLM identifiers UMLS ID C0216660 and NCI Concept Code C47786. SMILES: O1C(C(NC(=O)C)C(/N=C(/N)N)C=C1C(=O)O)C(O)C(O)CO.